Hong Kong stocks surge on pharmaceutical and technology gains

Hong Kong's stock market climbed during Tuesday's trading session, with pharmaceutical and technology companies leading the gains across the bourse. The sector-driven advance suggests investor confidence is returning to growth-oriented equities in the Asian financial hub.

Pharmaceutical stocks benefited from renewed interest in healthcare-related investments, while technology shares capitalized on broader momentum in the sector. The dual-sector rally points to shifting market sentiment favoring innovation and healthcare-related businesses.

Meanwhile, United Overseas Bank (UOB) has signalled expectations of stability in residential property markets throughout 2026. According to the bank's outlook, property prices in the region are likely to consolidate rather than experience significant volatility during the coming year, suggesting a period of relative equilibrium in the housing sector.

The property market assessment reflects broader economic expectations as investors assess regional real estate valuations. UOB's forecast indicates measured confidence in residential markets, with prices expected to maintain current levels amid steady economic conditions.